| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/17/2008 | US20080090918 Macroporous gel; cooling aqueous solution of gel forming polymer and solvent at a temperature which freezes solvent |
| 04/17/2008 | US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/17/2008 | US20080090843 Pharmaceutical formulation for treatment of HBV infection comprising a compound that inhibits the activity of a Src kinase in an amount effective to inhibit HBV replication and a pharmaceutically acceptable carrier |
| 04/17/2008 | US20080090763 Novel gene encoding a dna repair enzyme and methods of use thereof |
| 04/17/2008 | US20080090745 Host cells with inactivated protease genes; point mutations; cultures; laundry detergents |
| 04/17/2008 | US20080090291 Synthetic nucleic acid molecule compositions and methods of preparation |
| 04/17/2008 | US20080090280 Polypeptides Of Botryospaeria Rhodina |
| 04/17/2008 | US20080090279 Expression vector comprising nucleotide sequences coding lactase/hydrolase for use in production of low lactose milk in mammals |
| 04/17/2008 | US20080090278 Method for enhancing stability of a composition comprising soluble glucose dehydrogenase (gdh) |
| 04/17/2008 | US20080090277 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 04/17/2008 | US20080090272 Metabolic engineering of amino acid production |
| 04/17/2008 | US20080090271 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 04/17/2008 | US20080090263 Two secretory luciferases |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089878 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080087843 Method of controlling quantum dot photoluminescence and other intrinsic properties through biological specificity |
| 04/17/2008 | US20080087226 Animal litter having the property of detecting diabetes in felines |
| 04/17/2008 | CA2791144A1 Protease screening methods and proteases identified thereby |
| 04/17/2008 | CA2683122A1 Therapy targeting cathepsin s |
| 04/17/2008 | CA2666536A1 Compositions and methods of using chondroitinase abci mutants |
| 04/17/2008 | CA2665595A1 Glucoamylase variants with altered properties |
| 04/17/2008 | CA2663959A1 Plants with increased yield |
| 04/17/2008 | CA2603132A1 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 04/16/2008 | EP1911846A2 Genes which encode proteins for glucose-6-phosphate-dehydrogenase |
| 04/16/2008 | EP1911841A1 Methods for production of proteins |
| 04/16/2008 | EP1911839A1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method |
| 04/16/2008 | EP1911838A1 Crystalline forms of PKC alpha kinase, methods of making such crystals, and uses thereof |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911460A1 Pharmaceutical composition for promoting axonal re-growth and behaviour recovery in spinal cord injury |
| 04/16/2008 | EP1910552A1 Methods and compositions for modulating cox |
| 04/16/2008 | EP1910541A1 Cytotoxic ribonuclease variants |
| 04/16/2008 | EP1910534A2 Dna binding protein-polymerase chimeras |
| 04/16/2008 | EP1910532A2 Use of esterases for separating plastics |
| 04/16/2008 | EP1910531A1 Synergistic effect of the combination of phytases on hydrolysis of phytic acid |
| 04/16/2008 | EP1910530A2 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/16/2008 | EP1910529A2 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes |
| 04/16/2008 | EP1910528A2 Rna-dependent rna-polymerase, methods and kits for amplifying and/or marking rna |
| 04/16/2008 | EP1910527A1 Maltose-1-phosphate-producing enzyme |
| 04/16/2008 | EP1910525A1 Modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1910524A1 Modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1910523A1 Modulation of egfr signalling by modulation of sphingosine kinase signalling |
| 04/16/2008 | EP1910514A2 Recombinant yeasts for synthesizing epoxide hydrolases |
| 04/16/2008 | EP1910421A2 Compositions and methods for metabolic selection of transfected cells |
| 04/16/2008 | EP1909778A1 Sensitization of immune system against haptenized melanoma antigens |
| 04/16/2008 | EP1778837B1 Treatment of neurodegenerative diseases by the use of scd4 inhibitors |
| 04/16/2008 | EP1759206A4 Cdk9 as modifier of the igf pathway and methods of use |
| 04/16/2008 | EP1758994A4 Aldos as modifiers of the igf pathway and methods of use |
| 04/16/2008 | EP1720995A4 Methods and compostions for targeted cleavage and recombination |
| 04/16/2008 | EP1720901A4 Polypeptide having function of cinnamyl alcohol dehydrogenase, a polynucleotide coding the polypeptide and those uses |
| 04/16/2008 | EP1651673B1 Methods for use of an lkb1/strad/mo25 complex |
| 04/16/2008 | EP1594855A4 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 04/16/2008 | EP1304389B1 Enzymatic unhairing agent for use in tanning for producing leather and method for enzymatic unhairing treatment |
| 04/16/2008 | EP1223952B1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/16/2008 | EP1222283B1 Dna immunization against chlamydia infection |
| 04/16/2008 | EP1210443B1 Method to determine the level of hydrogen sulfide in a sample and method to identify a sequence encoding a homocysteinase with a desired degree of specificity |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | EP0931093B1 Helicobacter pylori live vaccine |
| 04/16/2008 | CN101163717A Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 04/16/2008 | CN101161812A Streptococcus separating method for kabikinase fermentation liquor |
| 04/16/2008 | CN101161811A Method for sifting and cultivating bacillus thuringiensis of high-yield thermostable proteinase |
| 04/16/2008 | CN100381620C Preparation method of original bamboo fiber by bioenzyme method |
| 04/16/2008 | CN100381572C Gene encoding flavone synthase |
| 04/16/2008 | CN100381569C Process for producing microbial transglutaminase |
| 04/16/2008 | CN100381567C Soybean diglyceride acyltransferase, its coding gene and use |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/16/2008 | CN100381528C Preparation method of undenatured fish scale collagen |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/15/2008 | US7358418 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhamced shelf life |
| 04/15/2008 | US7358352 Tumor necrosis factor; isolating protein from cell culture; use in drug discovery screens compounds that block synthesis |
| 04/15/2008 | US7358339 PRO polypeptide without the N-terminal signal sequence and/or the initiating methionine is encoded by a nucleotide sequence |
| 04/15/2008 | US7358334 B cell-targeted toxins for humoral immune response reduction and methods of use thereof |
| 04/15/2008 | US7358234 Induction of a protective immune response through microprojectiles coated with a DNA sequence encoding an immunogenic protein |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358073 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4- pyrimidinyl)-amino-2-cyclopentenyl-1-methanol |
| 04/15/2008 | US7358071 Production of 3-hydroxycarboxylic acid using nitrilase mutants |
| 04/15/2008 | US7358067 Genetic engineering; forming protein, peptide, polypeptide |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/12/2008 | CA2579184A1 Augmenting stem cell populations by modulating t-cell protein tyrosine phosphatase (tc-ptp) |
| 04/10/2008 | WO2008042876A2 Compositions and methods for producing stereoisomerically pure statins and synthetic intermediates therefor |
| 04/10/2008 | WO2008042235A2 Thermotoga neapolitana dsm 5068 alkaline phosphatase (phoa) gene and recombinant enzyme production |
| 04/10/2008 | WO2008041825A1 Mutant dna polymerases and their genes |
| 04/10/2008 | WO2008041385A1 Novel alkane polyol dehydrogenase |
| 04/10/2008 | WO2008041272A1 Novel highly active modified type s-hydroxynitrile lyase |
| 04/10/2008 | WO2008040787A2 Processes for producing polyunsaturated fatty acids in transgenic organisms |
| 04/10/2008 | WO2008040740A1 Lipolytic enzyme variants |
| 04/10/2008 | WO2008040739A2 Lipolytic enzyme variants |
| 04/10/2008 | WO2008040738A1 Lipolytic enzyme variants |
| 04/10/2008 | WO2008040731A2 Production of beta-lactam antibiotics |
| 04/10/2008 | WO2008040466A1 Clonation, expression and use of acid phospholipases |
| 04/10/2008 | WO2008040465A1 Clonation, expression and use of acid lysophospholipases |
| 04/10/2008 | WO2008010925A3 Protease variants active over a broad temperature range |
| 04/10/2008 | WO2008009895A3 Matriptase-2 |
| 04/10/2008 | WO2008009855A3 Modulators of sc4mol in the treatment of acne or of hyperseborrhoea |
| 04/10/2008 | WO2007122210A3 Proline-specific proteases free from amylolytic activities |
| 04/10/2008 | WO2007116089A3 Proder p 1 expressed in a prokaryotic cell |
| 04/10/2008 | WO2007103523A9 Antioxidant protein, compositions, and methods of use |
| 04/10/2008 | WO2007101678A3 Methods for increasing shoot-to-root ratio, seed production and resistance to diseases |